Skip Navigation

Publication Detail

Title: Genetic susceptibility, obesity and lifetime risk of type 2 diabetes: The ARIC study and Rotterdam Study.

Authors: Ligthart, Symen; Hasbani, Natalie R; Ahmadizar, Fariba; van Herpt, Thijs T W; Leening, Maarten J G; Uitterlinden, André G; Sijbrands, Eric J G; Morrison, Alanna C; Boerwinkle, Eric; Pankow, James S; Selvin, Elizabeth; Ikram, M Arfan; Kavousi, Maryam; de Vries, Paul S; Dehghan, Abbas

Published In Diabet Med, (2021 10)

Abstract: AIMS: Both lifestyle factors and genetic background contribute to the development of type 2 diabetes. Estimation of the lifetime risk of diabetes based on genetic information has not been presented, and the extent to which a normal body weight can offset a high lifetime genetic risk is unknown. METHODS: We used data from 15,671 diabetes-free participants of European ancestry aged 45 years and older from the prospective population-based ARIC study and Rotterdam Study (RS). We quantified the remaining lifetime risk of diabetes stratified by genetic risk and quantified the effect of normal weight in terms of relative and lifetime risks in low, intermediate and high genetic risk. RESULTS: At age 45 years, the lifetime risk of type 2 diabetes in ARIC in the low, intermediate and high genetic risk category was 33.2%, 41.3% and 47.2%, and in RS 22.8%, 30.6% and 35.5% respectively. The absolute lifetime risk for individuals with normal weight compared to individuals with obesity was 24% lower in ARIC and 8.6% lower in RS in the low genetic risk group, 36.3% lower in ARIC and 31.3% lower in RS in the intermediate genetic risk group, and 25.0% lower in ARIC and 29.4% lower in RS in the high genetic risk group. CONCLUSIONS: Genetic variants for type 2 diabetes have value in estimating the lifetime risk of type 2 diabetes. Normal weight mitigates partly the deleterious effect of high genetic risk.

PubMed ID: 34245042 Exiting the NIEHS site

MeSH Terms: No MeSH terms associated with this publication

Back
to Top